{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-112356","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-09-30T20:30:22+00:00","discovered_at":"2026-09-30T20:31:00.245811+00:00","generated_at":"2026-10-12T14:06:50.164960+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Outlook Therapeutics receives Nasdaq notice for bid price below $1.00, has until March 24, 2027 to regain compliance","bullets":["Nasdaq notified Outlook Therapeutics on Sept 25, 2026 that its closing bid price was below $1.00 for 30 consecutive business days, violating Rule 5550(a)(2).","The company has 180 calendar days, until March 24, 2027, to regain compliance, requiring a closing bid price of at least $1.00 for 10 consecutive business days.","Outlook may qualify for an additional 180-day period and could effect a reverse stock split to cure the deficiency.","If not cured by the Compliance Date, Nasdaq will notify of delisting; the company may appeal to a hearings panel, but success is not assured.","CFO Kevin Lundquist signed the Form 8-K dated September 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-112356","json":"https://secwatch.observer/filing/0001104659-26-112356.json","markdown":"https://secwatch.observer/filing/0001104659-26-112356.md","text":"https://secwatch.observer/filing/0001104659-26-112356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926112356/0001104659-26-112356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465926112356/tm2626478d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:06:50.164960+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}